Search clinical trials for: IONIS ANGPTL3-LRx
Total 609 results
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1Canada
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedHypertriglyceridemia | Familial HypercholesterolemiaCanada
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.WithdrawnHomozygous Familial HypercholesterolemiaCanada
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.CompletedHealthy VolunteersCanada
-
Ionis Pharmaceuticals, Inc.RecruitingHereditary Transthyretin-Mediated Amyloid PolyneuropathyUnited States, Italy, Portugal, Spain, Taiwan, Sweden, Canada, Brazil, France, New Zealand, Argentina, Cyprus, Australia, Turkey
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.Active, not recruitingTransthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)United States, Australia, Spain, Canada, Germany, Japan, Italy, Israel, Argentina, France, Portugal, Austria, Brazil, Greece, United Kingdom, Czechia, Sweden, Belgium, Denmark, Poland, Puerto Rico
-
Ionis Pharmaceuticals, Inc.RecruitingPhlebotomy Dependent Polycythemia VeraUnited States, Canada, Hungary, United Kingdom, Australia, Poland
-
Ionis Pharmaceuticals, Inc.TerminatedBeta Thalassemia IntermediaAustralia, Thailand, Greece, Lebanon, Turkey
-
Ionis Pharmaceuticals, Inc.RecruitingHereditary AngioedemaUnited States, Puerto Rico, Belgium, Bulgaria, Canada, France, Germany, Israel, Italy, Netherlands, Poland, Spain, Turkey, United Kingdom
-
Ionis Pharmaceuticals, Inc.Active, not recruitingHereditary AngioedemaNetherlands, United States
-
Ionis Pharmaceuticals, Inc.Active, not recruitingPrimary IgA NephropathyCanada, Australia, New Zealand, Singapore
-
Ionis Pharmaceuticals, Inc.CompletedAcromegalyUnited States, Hungary, Serbia, Estonia, Italy, Latvia, Lithuania, Poland, Romania, Russian Federation
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.CompletedHereditary Transthyretin-Mediated Amyloid PolyneuropathyUnited States, Spain, Taiwan, Italy, Germany, Argentina, Australia, Brazil, Canada, Cyprus, France, Greece, New Zealand, Portugal, Sweden, Turkey
-
Ionis Pharmaceuticals, Inc.CompletedAcromegalyUnited States, Hungary, Serbia, Romania, Russian Federation, Lithuania, Poland
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Partial LipodystrophyUnited States
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedCardiovascular Diseases | HypertriglyceridemiaUnited States, Canada
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompleted
-
Ionis Pharmaceuticals, Inc.WithdrawnGeographic Atrophy | Age Related Macular DegenerationAustralia, United States, New Zealand
-
Ionis Pharmaceuticals, Inc.CompletedChronic Heart Failure With Reduced Ejection FractionUnited States, Hungary, Poland
-
Ionis Pharmaceuticals, Inc.Active, not recruitingMacular Degeneration | Geographic AtrophyUnited States, Spain, Australia, Austria, Canada, Czechia, Netherlands, New Zealand, Poland
-
Ionis Pharmaceuticals, Inc.Completed
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedCardiovascular Disease | Elevated Lipoprotein(a)United States, Canada, Denmark, Germany, Netherlands
-
Ionis Pharmaceuticals, Inc.CompletedHereditary AngioedemaUnited States, Netherlands
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.CompletedHealthy Volunteers | hATTR AmyloidosisCanada
-
Ionis Pharmaceuticals, Inc.CompletedAmyloidosis | Familial Amyloid Polyneuropathy | FAP | TTR | TransthyretinUnited States, Spain, Argentina, Brazil, France, Germany, Italy, Portugal, United Kingdom
-
BiogenCompleted
-
Ionis Pharmaceuticals, Inc.CompletedAmyloidosis | Familial Amyloid Polyneuropathy | FAP | TTR | TransthyretinNew Zealand, United States, Spain, Argentina, Brazil, France, Germany, Italy, Portugal, United Kingdom
-
BiogenCompleted
-
Ionis Pharmaceuticals, Inc.BayerCompletedEnd-stage Renal Disease (ESRD)Canada
-
BiogenCompletedSpinal Muscular AtrophyUnited States, Spain, Germany, United Kingdom, Australia, Japan, Canada, Belgium, France, Hong Kong, Italy, Korea, Republic of, Sweden, Turkey
-
BiogenCompletedSpinal Muscular AtrophyUnited States
-
BiogenCompletedSpinal Muscular AtrophyUnited States, Canada
-
BiogenTerminatedSpinal Muscular AtrophyKorea, Republic of, United States, Spain, Canada, Germany, Australia, Japan, Sweden, Belgium, France, Italy, Turkey, United Kingdom
-
BiogenCompletedSpinal Muscular AtrophyUnited States, Germany, Spain, Canada, France, Hong Kong, Italy, Japan, Korea, Republic of, Sweden
-
Ionis Pharmaceuticals, Inc.CompletedCystic Fibrosis | Healthy SubjectsUnited Kingdom, Germany
-
Ionis Pharmaceuticals, Inc.CompletedHepatic SteatosisCanada, Hungary, Poland, United Kingdom
-
University of ChicagoNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Ionis Pharmaceuticals, Inc.AstraZenecaCompletedLymphoma | DLBCL | Advanced CancersUnited States
-
Ionis Pharmaceuticals, Inc.CompletedMyotonic Dystrophy Type 1United States
-
Smith, Timothy R., M.D.Ionis Pharmaceuticals, Inc.; Clinvest Research, LLCCompletedChronic MigraineUnited States
-
Ionis Pharmaceuticals, Inc.CompletedMild Alzheimer's DiseaseUnited Kingdom, Netherlands, Germany, Sweden, Canada, Finland
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1United States, Canada, Germany, Israel, Italy, South Africa, Spain, United Kingdom, Brazil, France, Netherlands
-
Ionis Pharmaceuticals, Inc.CompletedAcromegalyUnited States, Serbia, Poland, Russian Federation, Hungary, Lithuania
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.TerminatedFamilial Partial LipodystrophyUnited States, Netherlands, Belgium, Brazil, Canada, Germany, Russian Federation